Carboxymethyl chitosan dopamine conjugates: Synthesis and evaluation for intranasal anti Parkinson therapy-Reference-Cited by-同舟云学术

Carboxymethyl chitosan dopamine conjugates: Synthesis and evaluation for intranasal anti Parkinson therapy

Published:2023-12 Issue: Volume:253 Page:127174
ISSN:0141-8130
Container-title:International Journal of Biological Macromolecules
language:en
Short-container-title:International Journal of Biological Macromolecules

Author:

Di Gioia Sante,Fracchiolla Giuseppe,Cometa Stefania,Perna Filippo Maria,Quivelli Andrea Francesca,Trapani Giuseppe,Daniello Valeria,Nobile Concetta,Hossain Md Niamat,Trapani Adriana,Conese Massimo

Publisher

Elsevier BV

Subject

Molecular Biology,General Medicine,Biochemistry,Structural Biology

Reference46 articles.

1. Neurodegenerative disease: models, mechanisms, and a new hope;Gitler;Dis. Model. Mech.,2017

2. Targeting autophagy, oxidative stress, and ER stress for neurodegenerative disease treatment;Esmaeili;J. Control. Release,2022

3. Advances in the treatment of neurodegenerative disorders employing nanoparticles;Spuch;Recent Pat. Drug Deliv. Formul.,2012

4. Parkinson disease: not just a movement disorder;Pandya;Cleve. Clin. J. Med.,2008

5. A review of patient-specific gastrointestinal parameters as a platform for developing in vitro models for predicting the in vivo performance of oral dosage forms in patients with Parkinson’s disease;Wollmer;Int. J. Pharm.,2017

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A review of chitosan-based nanocarriers as drug delivery systems for brain diseases: Critical challenges, outlooks and promises;International Journal of Biological Macromolecules;2024-10

2. O-carboxymethyl chitosan in biomedicine: A review;International Journal of Biological Macromolecules;2024-08

3. The nanocarrier strategy for crossing the blood-brain barrier in glioma therapy;Chinese Chemical Letters;2024-05

4. Intranasal Therapy in Palliative Care;Pharmaceutics;2024-04-09